Biphasic insulin aspart vs Empagliflozin
National NHS prescribing compared (Prescription Cost Analysis)
Empagliflozin was dispensed 6.8× as often as Biphasic insulin aspart in May 2026 — 323,972 items versus 47,490 in England.
47,490items
Biphasic insulin aspart · May 2026
NHSBSA Prescription Cost Analysis
323,972items
Empagliflozin · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Biphasic insulin aspart versus Empagliflozin: national items dispensed by month
▬ Biphasic insulin aspart · ╌ Empagliflozin
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Biphasic insulin aspart | Empagliflozin |
|---|---|---|
| Items, May 2026 | 47,490 | 323,972 |
| Items, last 12 months | 608,257 | 4,615,976 |
| Net ingredient cost, May 2026 | £2,235,763 | £12,500,182 |
See the full profile for Biphasic insulin aspart or Empagliflozin.